$JNJ Is Coming for a New High

$Johnson & Johnson(JNJ)$

$Johnson & Johnson (JNJ) Closes +2.01% at $271.19: Defensive Pharma Giant Nears 52-Week High, $276.47 Breakout in Sight

Latest Close Data: JNJ ended at $271.19, up +2.01% (+$5.34) on Sep 2. The stock is just 1.9% below its 52-week high of $276.47 and far above the 52-week low of $173.33. 📈

Core Market Drivers: Strength reflects defensive rotation into healthcare. Guggenheim raised its JNJ target to $287 on Aug 6, with Argus setting $300 and Wells Fargo at $282. Short interest remains elevated (16.8% of volume on 8/31), fueling squeeze potential as price grinds higher. 💊

Technical Analysis: MACD is turning constructive — DIF (4.52) sits above DEA (3.94), though the histogram is still mildly negative, suggesting early-stage momentum recovery. RSI(6) at 59.6 and RSI(12) at 58.9 signal strengthening bullish pressure without being overbought. Volume of 6.04M shares was moderate. 📊

Key Price Levels:

  • 🛡️ Primary Support: $265.85 (prior close, now first defense)

  • 💪 Strong Resistance: $276.47 (52-week high — breakout trigger)

  • ⚡ Immediate Pivot: $269.35 (Aug 31 resistance flipping to support)

Valuation Perspective: P/E TTM at 31.4 is notably above its 5-year forward P/E average of ~16.9 and current forward P/E of 22.96, while P/S stands at 6.67. The market is pricing in pipeline optimism, not just defensive yield. 💰

Analyst Targets: 24 analysts cover JNJ with average target $270.38 — essentially at current price. Distribution: 6 Strong Buy, 13 Buy, 8 Hold. The flat average suggests near-term consolidation, but recent upward revisions point to a rising target trajectory. 🎯

Weekly Outlook: Expect a test of $276.47 within days. A decisive breakout opens the path to $287–$300 (analyst targets). Failure to hold $265.85 could trigger a pullback toward $257–260, filling the late-August gap. Range forecast: $265–$280. 🔭

⚠️ Risk Disclaimer: This technical summary is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results. Always conduct your own research before trading.

🎯$Johnson & Johnson (JNJ) Options Strategy: Bull Call Spread

  • Underlying: JNJ

  • View: Cautiously bullish, testing 52-week high breakout

  • Strategy Type: Debit spread / defined-risk directional long

  • Option Contract Portfolio:

    • Buy 1 JNJ 2026-09-18 270 Call @ $4.30 (mid)

    • Sell 1 JNJ 2026-09-18 280 Call @ $0.96 (mid)

  • Max Gain & Loss:

    • Max Gain: $666 per spread (=$10 width - $3.34 net debit, ×100)

    • Max Loss: $334 per spread (net debit)

  • Initial Cost/Credit: $3.34 net Debit per share ($334 per contract)


Investing is a long journey. Knowing when to move matters — and so does knowing when to recharge.

Markets may not slow down, but you can. Whether it’s a quick break between trading sessions or a long journey, staying comfortable helps you reset for what comes next. The new Night Trading Memory Foam Pillow features 360° ergonomic support and slow-rebound memory foam that gently conforms to your neck, plus a roll-up design that makes it easy to bring wherever you go.

https://laohu8.com/J/redeemGift?goodID=100540&type=delivery

Redeem the new Night Trading Memory Foam Pillow in Tiger Coins Mall, and stay supported for the journey ahead.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet